At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 119 enrolled
Drug / intervention
EVO101drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Vehicle-controlled, Safety and Efficacy Study of EVO101 in Adult Subjects With Atopic Dermatitis
In Brief
A Phase 2 clinical trial evaluating EVO101 for Atopic Dermatitis Eczema. Completed, enrolled 119 participants across 21 sites.
Detailed Summary
This is a Phase 2a safety and efficacy study of EVO101 for the treatment of adults with atopic dermatitis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis Eczema
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2023202420252026
Enrollment StartSep 2022
First PostedOct 2022
Primary CompletionJul 2023
TodayJul 2026
First PostedOct 14, 2022
Enrollment StartSep 27, 2022
Primary CompletionJul 27, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.7 years ago
Interventions
EVO101drug
Topical Cream